Skip to main content
OpenTrials

Clinical trial condition

Urogenital Neoplasms

Explore clinical trials studying Urogenital Neoplasms. Study availability and eligibility vary by location and protocol.

12,007 public trials 2,555 recruiting studies
Refine in advanced search Browse all conditions

Urogenital Neoplasms trial results

Recruiting

DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer

NCT06964009

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +16 more
Locations
  • Beth Israel Deaconess Medical Center (BIDMC) Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
View Trial Details
Recruiting

A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)

NCT07222488

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Michael G Oefelein Clinical Trials ( Site 0005) Bakersfield, California, United States
  • Carolina Urologic Research Center ( Site 0006) Myrtle Beach, South Carolina, United States
  • Medizinische Universität Wien ( Site 0021) Vienna, State of Vienna, Austria
  • UZ Gent ( Site 0031) Ghent, Oost-Vlaanderen, Belgium
View all 17 locations
View Trial Details
Recruiting

REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma

NCT07594106

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations
  • City of Hope Phoenix Goodyear, Arizona, United States
  • City of Hope Duarte, California, United States
  • City of Hope Chicago, City of Hope Cancer Center Chicago Zion, Illinois, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

NCT06056830

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • University of Alabama Birmingham Hospital Birmingham, Alabama, United States
  • Mayo Clinic- Phoenix Phoenix, Arizona, United States
  • Arkansas Urology Research Center, LLC Little Rock, Arkansas, United States
  • Urology Group of Southern California Los Angeles, California, United States
View all 34 locations
View Trial Details
Recruiting

A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer

NCT07570979

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Mary Crowley Cancer Research Dallas, Texas, United States
  • Novartis Investigative Site Melbourne, Victoria, Australia
  • Novartis Investigative Site Hirakata, Osaka, Japan
  • Novartis Investigative Site Montreal, Quebec, Canada
View Trial Details

Related conditions